I-RESPOND Evaluation of IRbESartan (with or without HCTZ) in imProving insulin sensitivity in hypertensive patients with metabOlic syNDrome Logo (EUIPO, 11/15/2006)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark I-RESPOND Evaluation of IRbESartan (with or without HCTZ) in imProving insulin sensitivity in hypertensive patients with metabOlic syNDrome was filed as Figurative mark on 11/15/2006 at the European Union Intellectual Property Office.
It was registered as a trademark on 09/19/2007.
The current status of the mark is "Registration expired".
Logodesign (Wiener Klassifikation)
#One line or one band #Curved lines or bands (except A 26.11.13) #Red, pink, orange
| Trademark form | Figurative mark |
| File reference | 005501416 |
| Application date | November 15, 2006 |
| Publication date | May 14, 2007 |
| Entry date | September 19, 2007 |
| Expiration date | November 15, 2016 |
Trademark owner
46 avenue de la Grande Armée
75017 Paris
FR
75017 Paris
FR
Trademark representatives
54, rue La Boétie
75008 Paris
FR
goods and services
42
Scientific research for medical purposes; medical research (designing new products in the cardiovascular field); clinical studies
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| September 15, 2017 | Extension, Trade mark expired | ||
| March 10, 2017 | Transfer / Change of address, Published | ||
| October 18, 2012 | Transfer / Change of address, Published | ||
| March 7, 2012 | Change Representative, Published | ||
| February 23, 2012 | Transfer / Change of address, Published | ||
| January 30, 2012 | Transfer / Change of address, Published | ||
| May 23, 2011 | Transfer / Change of address, Published | ||
| December 1, 2009 | Change Representative, Registered |
ID: 11005501416